Mustafa Salih Karatepe

Dr. Mustafa Salih Karatepe

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2022 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
AKAli Keles
Ali Keles
AKAli Karayagmurlu
Ali Karayagmurlu
EYEsat Yetkin
Esat Yetkin
KSKenan Sonmez
Kenan Sonmez
MKMustafa Salih Karatepe
Mustafa Salih Karatepe
SKSuleyman Korhan Karaman
Suleyman Korhan Karaman

10 March 2021 in Seminars in Ophthalmology
Verified
Journal Article
Closed access
CACemile Ucgul Atilgan
Cemile Ucgul Atilgan
KAKadir Gökhan Atılgan
Kadir Gökhan Atılgan
PKPınar Kösekahya
Pınar Kösekahya
YGYasin Sakir Goker
Yasin Sakir Goker
MKMustafa Salih Karatepe
Mustafa Salih Karatepe
MCMehmet Citirik
Mehmet Citirik
To investigate the effect of microalbuminuria (MA) on superficial vessel density (SVD), deep vessel density (DVD), and choriocapillaris vessel density (CVD) in type-2 diabetic patients.Twenty patie...

2 December 2025 in Scientific Reports
Verified
Journal Article
Open access
MKMustafa Salih Karatepe
Mustafa Salih Karatepe
DYDuygu Yalinbaş Yeter
Duygu Yalinbaş Yeter
Triglyceride-glucose index as a potential biomarker for predicting retinal vein occlusion

25 June 2024 in International Ophthalmology
Verified
Journal Article
Closed access
PDF file
MKMustafa Salih Karatepe
Mustafa Salih Karatepe
EBErman Bozali
Erman Bozali

3 January 2025 in Sağlık Bilimlerinde Değer
Verified
Journal Article
Open access
PDF file
MKMustafa Salih Karatepe
Mustafa Salih Karatepe
DYDuygu Yalınbaş Yeter
Duygu Yalınbaş Yeter
Aim: To evaluate the clinical and demographic characteristics of geriatric patients who apply to the emergency department with ophthalmic complaints, to determine risk factors, design appropriate prevention strategies, and improve existing ones. Material and Methods: The records of patients aged ≥ 65 years who applied to the emergency department with ophthalmic complaints were evaluated retrospectively. The patients were divided into two groups traumatic and non-traumatic based on their presenting complaints. Results: The study included two hundred-five patients with a median age of 72 (65-100). Among the patients, 81 (39.51%) were women with a median age of 74 (65-100), and 124 (60.48%) were men with a median age of 71.5 (65-93). One hundred and twenty-four (60.48%) of the patients were admitted for traumatic reasons and 81 (39.51%) for non-traumatic reasons. Of the patients admitted for traumatic reasons, 25 (20.16%) were women and 99 (79.83%) were men; Of the patients admitted for non-traumatic reasons, 56 (69.13%) were women and 25 (30.86%) were men. Falls (24.19%) were the most common in those admitted for traumatic reasons. According to gender, eye traumas were statistically significantly more common in men than in women (p

5 October 2024 in Güncel Retina Dergisi (Current Retina Journal)
Verified
Journal Article
Open access
PDF file
MKMustafa Salih Karatepe
Mustafa Salih Karatepe
Vascular endothelial growth factor (VEGF) is an important mediator of pathological neovascularization and vascular permeability of the eye. The increasing use of intravitreal therapies targeting VEGF has revolutionized the treatment of pediatric vitreoretinal diseases. Laser photocoagulation is the standard treatment method for retinopathy of prematurity. The aim is to ablate the avascular peripheral retina, but ablation of the peripheral retina with traditional laser therapy is destructive, causes complications, and does not prevent all vision loss, especially in cases of retinopathy of prematurity affecting zone 1 of the eye. In Coats disease, retinal telangiectasias are treated early with laser photocoagulation, but with ischemia, high levels of VEGF in the ocular fluid may contribute to increased permeability of telangiectatic blood vessels, leading to lipoprotein leakage and subsequent exudative retinal detachment. Therefore, anti-VEGF has been recommended as adjuvant therapy in the treatment of Coats disease. In this review, intravitreal injection and prophylactic laser treatment applications in Retinopathy of Prematurity and Coats Disease are mentioned.